Latest News - Management/Leadership

Tuesday, December 12, 2017 | Management/Leadership

Eyevensys Appoints Patricia Zilliox, PhD, as Chief Executive Officer

Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, announced the appointment of Patricia Zilliox. PhD, as CEO. Dr. Zilliox, who joined the Eyev…

Read the full story

Tuesday, December 12, 2017 | Management/Leadership, Carl Zeiss Meditec

New Members of the Executive Board of the Zeiss Group

The Supervisory Board of Carl Zeiss AG has expanded the Executive Board of the Zeiss Group, which currently has four members. This is in line with the implementation of the Zeiss portfolio strategy an…

Read the full story

Monday, December 11, 2017 | Management/Leadership, GrayBug

Graybug Vision Expands Executive Leadership Team

Graybug Vision announced the addition of four key members to its leadership team as it continues to advance its ocular treatments through clinical development and evolve into a commercial biotech comp…

Read the full story

Wednesday, December 06, 2017 | Management/Leadership, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer

NovaBay Pharmaceuticals announced the appointment of Lewis J. Stuart as Chief Commercial Officer. Mr. Stuart joined NovaBay on December 1 and brings more than 30 years of biopharmaceutical industry ex…

Read the full story

Friday, December 01, 2017 | Management/Leadership, Shire

Shire Appoints Andreas Busch, PhD, as Head of Research and Development and Chief Scientific Officer

Shire announced that Andreas (Andy) Busch, PhD, will join Shire as Executive Vice President, Head of Research and Development, and Chief Scientific Officer, and will become a member of the company'…

Read the full story

Wednesday, November 15, 2017 | Management/Leadership, Aerpio Therapeutics

Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer

Aerpio Pharmaceuticals announced that Michael Rogers has been appointed Chief Financial Officer effective as of November 15, 2017. Mr. Rogers has more than 25 years of experience in the biopharmaceuti…

Read the full story

Monday, November 13, 2017 | Management/Leadership, Kala Pharmaceuticals

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer

Kala Pharmaceuticals announced the appointment of Todd Bazemore as Chief Operating Officer of the company. He will report directly to Mark Iwicki, Chairman and Chief Executive Officer of Kala Pharmace…

Read the full story

Wednesday, November 08, 2017 | Management/Leadership

Ophthalmic Industry Leader William Link, PhD, Named Chairman of the Board at Lensar

Lensar has announced that William J. Link, PhD, has joined the company’s board of directors as its chairman. A well-known and respected ophthalmic industry leader, Dr. Link's appointment to …

Read the full story

Wednesday, November 08, 2017 | Management/Leadership, ThromboGenics

ThromboGenics Appoints Susan Schneider, MD, Chief Medical Officer, and Vinciane Vangeersdaele Chief Commercial Officer

ThromboGenics announced it has strengthened its senior leadership team with the appointment of Susan Schneider, MD, as Chief Medical Officer, and Vinciane Vangeersdaele as Chief Commercial Officer. Bo…

Read the full story

Wednesday, November 01, 2017 | Management/Leadership, Eyegate Pharmaceuticals

EyeGate Appoints Mike Garanzini as Chief Commercial Officer to Develop and Implement Global Launch Strategy

EyeGate Pharmaceuticals has appointed Mike Garanzini as Chief Commercial Officer, effective immediately. Mr. Garanzini will be responsible for developing and implementing the global launch and commerc…

Read the full story

Tuesday, October 31, 2017 | Management/Leadership, Bausch+Lomb

Former Bausch + Lomb CEO Dan Gill Has Died

A longtime former leader of Bausch + Lomb has died, according to a report on WXXI.org. Dan Gill, 81, who was CEO from 1981 to 1995, died on October 27, according to an obituary in the Democrat &…

Read the full story

Tuesday, October 17, 2017 | Management/Leadership, Foundation Fighting Blindness

Benjamin Yerxa Named Foundation Fighting Blindness CEO

The Foundation Fighting Blindness (FFB) announced that it has selected Benjamin Yerxa, a biotechnology and drug development executive, as its Chief Executive Officer, effective immediately. The Fou…

Read the full story

Monday, September 25, 2017 | Management/Leadership, Ocular Therapeutix

Ocular Therapeutix Appoints Donald Notman as Chief Financial Officer

Ocular Therapeutix announced the appointment of Donald Notman as Chief Financial Officer, effective immediately. Mr. Notman will replace interim CFO George Migausky and will be responsible for all str…

Read the full story

Friday, September 22, 2017 | Management/Leadership, SightLife Surgical

Robert J. Stevens Joins SightLife Surgical as Chief Technology Officer

SightLife Surgical announced that Bob Stevens has joined the company as its first Chief Technology Officer. In his new position, Bob will lead all product research and development, ensuring that the r…

Read the full story

Thursday, September 21, 2017 | Management/Leadership, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces Appointment of Tori Arens as Vice President of Drug Product Manufacturing and Eric Carlson, PhD, as Vice President of Research and Development

Aerie Pharmaceuticals announced the appointment of Tori Arens as Vice President of Drug Product Manufacturing, reporting to Kenneth Ruettimann, PhD, Aerie’s Vice President of Manufacturing. Aeri…

Read the full story
Load More